Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-κB ligand and macrophage colony-stimulating factor

Endocrinology

Volumn 141, Issue 10, 2000, Pages 3774-3782

  Samura, Atsuyoshi ^a   Wada, Seiki ^a   Suda, Satoru ^a   Iitaka, Makoto ^a   Katayama, Sigehiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCITONIN RECEPTOR; COLONY STIMULATING FACTOR 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MESSENGER RNA; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; SALCATONIN;

ARTICLE; ENZYME ACTIVATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION;

EID: 0033744997     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.10.7715     Document Type: Article

References (50)

1. Calcitonin
2. Calcitonin, an update
3. Calcitonin
4. Control of cyclic adenosine 3',5'-monophosphate production in osteoclasts: Calcitonin-induced persistent activation and homologous desensitization of adenylate cyclase
5. Histochemical and autoradiographic studies on elcatonin internalization and intracellular movement in osteoclasts
6. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells
7. Down-regulation of caIcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation
8. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase A-mediated mechanism
9. Modulation of osteoclast differentiation
10. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function
11. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
12. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
13. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
14. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
15. Glucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells
16. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
17. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts
18. The effect of PGF2α on parathyroid hormone-stimulated cyclic AMP production in mouse osteobiastic cell MC3T3E1
19. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells
20. Dansylcadaverine inhibits internalization of 125I-epidermal growth BALB 3T3 cells
21. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line
22. Isoforms of the rat calcitonin receptor: Consequences for ligand binding and signal transduction
23. 2+/inositol phosphate signaling pathways
24. Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity
25. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters
26. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells
27. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts
28. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA
29. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
30. Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism
31. Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts
32. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway
33. Cloning and characterization of an abundant subtype of the human calcitonin receptor
34. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D)
35. Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106-06) cells
36. Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways
37. Cytoskeleton-dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase
38. Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin
39. Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene
40. Calcitonin prevents CC14-induced hydroperoxide generation and cytotoxicity possibly through C1b receptor in rat hepatocytes
41. Cell cycle-dependent coupling of the calcitonin receptor to different G proteins
42. The calcitonin receptor stimulates Shc tyrosine phosphorylation and Erk1/2 activation. Involvement of Gi, protein kinase C, and calcium
43. Nasal calcitonin for treatment of established osteoporosis
44. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis
45. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: A double-blind, double-placebo study
46. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: A prospective study
47. Effect of elcatonin on involutional osteoporosis
48. Salmon calcitonin in the treatment of hypercalcemia
49. Escape from inhibition or resorption in cultures of fetal bone treated with calcitonin and parathyroid hormone
50. Functional significance of antibody formation after long-term calcitonin therapy